3-Amino-7-(methylamino)phenothiazin-5-ium chloride structure
|
Common Name | 3-Amino-7-(methylamino)phenothiazin-5-ium chloride | ||
|---|---|---|---|---|
| CAS Number | 531-57-7 | Molecular Weight | 277.77 | |
| Density | N/A | Boiling Point | 385.1ºC at 760 mmHg | |
| Molecular Formula | C13H12ClN3S | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 186.7ºC | |
Use of 3-Amino-7-(methylamino)phenothiazin-5-ium chlorideAzure C is the product of sequential enzymatic oxidation of Methylene blue (MB) or Azure B (AB). Azure C serves as the substrate of horseradish peroxidase (HRP)[1][2]. |
| Name | azure C |
|---|---|
| Synonym | More Synonyms |
| Description | Azure C is the product of sequential enzymatic oxidation of Methylene blue (MB) or Azure B (AB). Azure C serves as the substrate of horseradish peroxidase (HRP)[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Boiling Point | 385.1ºC at 760 mmHg |
|---|---|
| Molecular Formula | C13H12ClN3S |
| Molecular Weight | 277.77 |
| Flash Point | 186.7ºC |
| Exact Mass | 277.04400 |
| PSA | 79.18000 |
| LogP | 1.01270 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | SP5680000 |
| HS Code | 2934300000 |
|
~%
3-Amino-7-(meth... CAS#:531-57-7 |
| Literature: Materials Research Bulletin, , vol. 49, # 1 p. 544 - 551 |
| HS Code | 2934300000 |
|---|---|
| Summary | 2934300000. other compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
Bioorg. Med. Chem. Lett. 19 , 4952-7, (2009) Aggregated amyloid-beta (Abeta) peptide is implicated in the pathology of Alzheimer's disease. In vitro and in vivo, these aggregates are found in a variety of morphologies, including globular oligome... |
|
|
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
J. Biol. Chem. 282 , 10311-24, (2007) Alzheimer disease is characterized by the abnormal aggregation of amyloid beta peptide into extracellular fibrillar deposits known as amyloid plaques. Soluble oligomers have been observed at early tim... |
|
|
Note from the Biological Stain Commission: revision of azure B assay protocol.
Stain Technol. 63(1) , 65-9, (1988)
|
| (7-aminophenothiazin-3-ylidene)-methylazanium,chloride |
| MFCD00067677 |
| N-Methylthionine |
| EINECS 208-512-8 |